Glipizide Renal Dosing: Is a CrCl Dose Adjustment Needed?
Antidiabetics · renal dosing
Glipizide has no creatinine clearance dose band. See its renal rule, the key caution, and what to monitor as kidney function changes.
Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Last reviewed October 2026.
Glipizide is not dosed by a creatinine clearance band: preferred sulfonylurea in CKD; caution.
Reviewed and approved by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Always confirm against the label.
Renal dosing at a glance
| Parameter | Value |
|---|---|
| Renal estimate used | no renal estimate (no adjustment) |
| Dose adjustment | Preferred sulfonylurea in CKD; caution |
| Key caution | hypoglycemia |
| Drug class | Antidiabetics |
How Glipizide Is Dosed When Kidney Function Falls
Glipizide has no creatinine clearance band in its renal rule, so the label does not scale the dose to a CrCl number. A missing band does not make the drug safe at every level of kidney function. The rule above (Preferred sulfonylurea in CKD; caution) still applies, and renal function guides monitoring, the choice between agents, and checks for class-specific effects. Active metabolites, electrolyte shifts, or heightened end-organ sensitivity can appear as kidney function falls. The summary above is reference-level; the linked FDA label is the authority for the exact numbers.
The Creatinine Clearance Dose-Band Framework
Most renally cleared drugs are adjusted across four broad creatinine clearance bands: above 50, 30-50, 15-30, and below 15 mL/min. Lowering the dose or lengthening the interval as clearance falls is the usual response. Glipizide's own rule (above) takes precedence over this general framework when the two differ, because each label sets its renal guidance from that drug's pharmacokinetics and therapeutic window.
| Creatinine clearance (mL/min) | Typical adjustment |
|---|---|
| > 50 | usually standard dosing |
| 30-50 | reduce dose or extend interval for many agents |
| 15-30 | further reduction; some drugs avoided |
| < 15 (or dialysis) | lowest dosing or an alternative agent; dialysis timing may matter |
Why Glipizide Still Needs Kidney Checks
Glipizide still needs kidney checks because related toxicities, electrolyte effects, or metabolites that the kidneys clear can matter even when the dose is not tied to a creatinine clearance band. Its parent-drug levels are expected to track kidney decline less closely than a renally cleared agent's. The rule above and routine monitoring continue regardless of the dose. Kidney function is still estimated from creatinine with age, sex, and body size, because the same creatinine maps to very different clearances in different patients.
Severe Impairment and Dialysis
At a creatinine clearance below 15 mL/min, or on dialysis, Glipizide still has no CrCl band to apply, so the rule above and the patient's measured response guide the decision, along with any metabolite or dialysis effects named in the label. Decisions at this level of kidney function are best made with pharmacy or nephrology input and the patient's measured response, not an estimate alone. See when dialysis is started for context.
How to Calculate CrCl for Glipizide
Estimate the patient's renal function first, then apply the threshold above. Use the creatinine clearance calculator (Cockcroft-Gault) with the right dosing weight: actual body weight when it is below ideal body weight, ideal body weight up to 130% of ideal, and adjusted body weight above 130% of ideal, as in obesity. A protocol or label that states its own weight rule takes priority. For example, a 70-year-old, 70 kg patient with a serum creatinine of 1.4 mg/dL has a Cockcroft-Gault creatinine clearance near 50 mL/min, close to the band where many drugs in this class need adjustment.
Monitoring and Re-Estimating
The key caution for Glipizide is hypoglycemia. Acute illness, dehydration, contrast, and other nephrotoxic drugs can lower kidney function within days, so re-estimate creatinine clearance whenever the clinical picture changes rather than relying on an old value. A creatinine that is still rising or falling has not reached steady state, and any estimate from it, including for Glipizide, is provisional until the value stabilises.
Re-check renal function and reconsider the Glipizide dose when any of the following appear, since each can signal falling clearance or early accumulation:
- a rising serum creatinine or a falling urine output;
- a new or worsened symptom consistent with hypoglycemia;
- a new nephrotoxic drug, contrast exposure, dehydration, or acute illness;
- a measured drug level outside its target range, where monitoring applies.
Special Populations
- Older adults: low muscle mass keeps serum creatinine deceptively normal, so clearance, and the safe Glipizide dose, can be lower than the lab value suggests.
- Obesity: total body weight overestimates clearance, so above 130% of ideal body weight the Cockcroft-Gault equation uses adjusted body weight instead.
- Acute kidney injury: a non-steady-state creatinine makes any estimate unreliable; dose conservatively and recheck.
Related Renal Dosing Rules
Neighbouring drugs in the antidiabetics class, with the rule each label sets:
- Canagliflozin renal dosing (by eGFR): <30 limited; per indication
- Dapagliflozin renal dosing (by eGFR): Glycemic efficacy <45 limited; CKD use >=25
- Empagliflozin renal dosing (by eGFR): Glycemic efficacy limited <30; per indication
- Glyburide renal dosing (by eGFR): Avoid in stage 3-5 CKD
- Metformin renal dosing (by eGFR): <30 contraindicated; 30-45 do not initiate / halve
- Saxagliptin renal dosing (by eGFR): <=45 -> 2.5 mg
Compare all 9 agents side by side in the antidiabetics renal dosing chart, or see related classes: cardiovascular (includes spironolactone, also labelled by eGFR).
Also without a CrCl dose band, in other classes: Ceftriaxone, Febuxostat, Linezolid, Meperidine.